Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-30

Clinical Trial Update: A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases [NA]

View source ↗

Summary

A prospective, open-label study evaluating the ACUSURGICAL Luca System for the treatment of vitreoretinal diseases is currently recruiting at a single center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACUSURGICAL Luca System

Snippet

Sponsor: Acusurgical | Conditions: Vitreoretinal Disease | NA | Status: RECRUITING